MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202621078928 A) filed by Ipca Laboratories Limited on June 25, 2026, for Mesalamine Prolonged Release Granules.
Inventors include Maheshwari, Hitesh Kumar; Nevle, Shyamkant; Singh, Deepak; Wawdhane, Sharad; and Desai, Makarand.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present invention relates to prolonged release pharmaceutical composition of Mesalamine granules comprising a bioenhancer. The prolonged release pharmaceutical composition of Mesalamine granules comprising a bioenhancer for use in ulcerative colitis and related inflammatory bowel diseases.
Disclaimer: Curated by HT Syn...